Source 1primary paper2025MED
Toolkit/peptide-based cancer vaccines
peptide-based cancer vaccines
Also known as: cancer vaccines
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Additionally, we summarize their application in ... cancer vaccines ...
Usefulness & Problems
Why this is useful
Peptide-based cancer vaccines are listed as one of the peptide application areas covered by the review. They are treated as part of the broader peptide oncology toolkit.; cancer vaccine applications using peptides
Source:
Peptide-based cancer vaccines are listed as one of the peptide application areas covered by the review. They are treated as part of the broader peptide oncology toolkit.
Source:
cancer vaccine applications using peptides
Problem solved
They provide a vaccine-oriented use of peptides in cancer diagnosis and therapy discussions. The review includes them among adaptable peptide platforms for personalized cancer care.; extends peptide engineering into vaccine-based oncology strategies
Source:
They provide a vaccine-oriented use of peptides in cancer diagnosis and therapy discussions. The review includes them among adaptable peptide platforms for personalized cancer care.
Source:
extends peptide engineering into vaccine-based oncology strategies
Problem links
extends peptide engineering into vaccine-based oncology strategies
LiteratureThey provide a vaccine-oriented use of peptides in cancer diagnosis and therapy discussions. The review includes them among adaptable peptide platforms for personalized cancer care.
Source:
They provide a vaccine-oriented use of peptides in cancer diagnosis and therapy discussions. The review includes them among adaptable peptide platforms for personalized cancer care.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Mechanisms
No mechanism tags yet.
Techniques
No technique tags yet.
Target processes
No target processes tagged yet.
Input: Chemical
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: actuator
The abstract supports that these approaches require peptide-based vaccine constructs. It does not specify adjuvants, delivery systems, or immunization regimens.; requires peptide use within cancer vaccine formats
The abstract does not provide evidence that peptide vaccines overcome all translational barriers or work uniformly across settings. Those details are outside the provided text.; specific efficacy or implementation limits are not detailed in the abstract
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
The review covers therapeutic peptides as targeting ligands, active agents, peptide-drug conjugates, peptide-guided radionuclides, and cancer vaccines.
Firstly, we outline the main functional classes of therapeutic peptides, covering their use as targeting ligands and their roles as active agents ... Additionally, we summarize their application in peptide-drug conjugates (PDCs), peptide-guided radionuclides, and cancer vaccines ...
A single peptide can serve as a targeting ligand, cell-penetrating motif, therapeutic effector, or structural component of peptide-drug conjugates, nanoparticle systems, and radionuclide constructs.
The same peptide can function as a targeting ligand, a cell-penetrating motif, a therapeutic effector, or a structural component of peptide-drug conjugates (PDCs), nanoparticle (NP) systems, and radionuclide constructs.
Approval Evidence
1 source1 linked approval claimfirst-pass slug peptide-based-cancer-vaccines
Additionally, we summarize their application in ... cancer vaccines ...
Source:
application scopesupports
The review covers therapeutic peptides as targeting ligands, active agents, peptide-drug conjugates, peptide-guided radionuclides, and cancer vaccines.
Firstly, we outline the main functional classes of therapeutic peptides, covering their use as targeting ligands and their roles as active agents ... Additionally, we summarize their application in peptide-drug conjugates (PDCs), peptide-guided radionuclides, and cancer vaccines ...
Source:
Comparisons
Source-stated alternatives
Other peptide modalities named in the abstract include targeting ligands, active therapeutic peptides, peptide-drug conjugates, nanoparticle systems, and peptide-guided radionuclides.
Source:
Other peptide modalities named in the abstract include targeting ligands, active therapeutic peptides, peptide-drug conjugates, nanoparticle systems, and peptide-guided radionuclides.
Source-backed strengths
included as a major peptide modality with mechanistic and clinical framing
Source:
included as a major peptide modality with mechanistic and clinical framing
Compared with peptide-drug conjugates
Other peptide modalities named in the abstract include targeting ligands, active therapeutic peptides, peptide-drug conjugates, nanoparticle systems, and peptide-guided radionuclides.
Shared frame: source-stated alternative in extracted literature
Strengths here: included as a major peptide modality with mechanistic and clinical framing.
Relative tradeoffs: specific efficacy or implementation limits are not detailed in the abstract.
Source:
Other peptide modalities named in the abstract include targeting ligands, active therapeutic peptides, peptide-drug conjugates, nanoparticle systems, and peptide-guided radionuclides.
Compared with peptide-guided radionuclides
Other peptide modalities named in the abstract include targeting ligands, active therapeutic peptides, peptide-drug conjugates, nanoparticle systems, and peptide-guided radionuclides.
Shared frame: source-stated alternative in extracted literature
Strengths here: included as a major peptide modality with mechanistic and clinical framing.
Relative tradeoffs: specific efficacy or implementation limits are not detailed in the abstract.
Source:
Other peptide modalities named in the abstract include targeting ligands, active therapeutic peptides, peptide-drug conjugates, nanoparticle systems, and peptide-guided radionuclides.
Ranked Citations
- 1.